Recombinant fusion protein linking factor VIIa with albumin (rVIIa­FP): Tissue distribution in rats

Wight, 2003, The epidemiology of inhibitors in haemophilia A: a systematic review, Haemophilia, 9, 418, 10.1046/j.1365-2516.2003.00780.x Ehrenforth, 1992, Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs, Lancet, 339, 594, 10.1016/0140-6736(92)90874-3 Erhardtsen, 2000, Pharmacokinetics of recombinant activated factor VII (VIIa), Semin Thromb Hemost, 26, 385, 10.1055/s-2000-8457 Weimer, 2008, Prolonged in-vivo half-life of factor VIIa by fusion to albumin, Thromb Haemost, 99, 659, 10.1160/TH07-08-0525 Schulte, 2012, Pioneering designs for recombinant coagulation factors, Thromb Res, 128, S9 Zollner, 2014, Pharmacological characteristics of a novel, recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP), J Thromb Haemost, 12, 220, 10.1111/jth.12477 Golor, 2013, Safety and pharmacokinetics of a recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP) in healthy volunteers, J Thromb Haemost, 11, 1977, 10.1111/jth.12409 Herzog, 2013, Biodistribution of rVIIa-FP, a recombinant fusion protein linking coagulation factor VIIa with albumin, in rats, Haemostaseologie, 33, P2 Müller, 1980, Protein labelling with 3H-NSP (N-succinimidyl-[2,3,-3H]propionate), J Cell Sci, 43, 319, 10.1242/jcs.43.1.319 Herzog, 2014, Biodistribution of the recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in rats, Thromb Res, 133, 900, 10.1016/j.thromres.2014.02.010 Ullberg, 1954, Studies on the distribution and fate of S35-labelled benzylpenicillin in the body, Acta Radiol Suppl, 118, 1 Caster, 1956, Tissue weights of the rat. I. Normal values determined by dissection and chemical methods, Exp Biol Med, 91, 122, 10.3181/00379727-91-22186 Beeby, 1993, Distribution of the recombinant coagulation factor 125I-rFVIIa in rats, Thromb Haemost, 70, 465, 10.1055/s-0038-1649606 Nakatomi, 2012, Pharmacokinetics, distribution, and excretion of 125I-labeled human plasma-derived-FVIIa and -FIX with MC710 (FVIIa/FX mixture) in rats, Thromb Res, 129, 62, 10.1016/j.thromres.2011.04.013 Gopalakrishnan, 2010, Bio-distribution of pharmacologically administered recombinant VIIa (rFVIIa), J Thromb Haemost, 8, 301, 10.1111/j.1538-7836.2009.03696.x Thomsen, 1993, Accumulation of the recombinant factor VIIa in rat bone: importance of the Gla-domain and relevance to factor IX, another vitamin K-dependent clotting factor, Pharmacol Toxicol, 73, 127, 10.1111/j.1600-0773.1993.tb01549.x Manco-Johnson, 2007, Prophylaxis versus episodic treatment to prevent joint disease in boys with severe haemophilia, N Engl J Med, 357, 535, 10.1056/NEJMoa067659 Zollner, 2014, Pharmacological characteristics of a novel, recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP), J Thromb Haemost, 12, 220, 10.1111/jth.12477 Weimer, 2013, Recombinant albumin fusion proteins, 163 Holton, 1987, Biodistribution of monoclonal IgG1, F(ab′)2, and Fab′ in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies, J Immunol, 139, 3041, 10.4049/jimmunol.139.9.3041 Schnitzer, 1993, High affinity binding, endocytosis, and degradation of conformationally modified albumins. Potential role of gp30 and gp18 as novel scavenger receptors, J Biol Chem, 268, 7562, 10.1016/S0021-9258(18)53212-9 Zollner, 2013, Pre­clinical safety and prolonged pharmacokinetic/pharmacodynamic (PK/PD) properties of a recombinant fusion protein linking activated coagulation factor VII with albumin (rVIIa-FP), J Thromb Haemost, 11, 480